FDA Inspection 1303206 — AGC Biologics, Inc.
The FDA completed an inspection of AGC Biologics, Inc. on May 29, 2026 in Bothell, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 29, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bothell, WA (United States)